secwatch.observer — SEC 8-K summary
======================================

Issuer:     ABVC BIOPHARMA, INC. (ABVC)
CIK:        0001173313
Form:       8-K
Filed at:   2023-07-31T23:59:59+00:00
Accession:  0001213900-23-061038
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ABVC BioPharma closes $1.75M registered direct offering of common stock and pre-funded warrants
--------------------------------------------------------------------------------

- Offering of 500,000 shares/pre-funded warrants at $3.50/share to a single institutional investor.
- Gross proceeds of $1.75 million before fees; net proceeds for R&D, working capital, and debt repayment.
- Wilmington Capital Securities acted as placement agent; offering through existing shelf registration.
- Closing occurred July 31, 2023, with all conditions satisfied.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1173313/000121390023061038/0001213900-23-061038-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1173313/000121390023061038/ea182578-8k_abvcbio.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-061038

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer